Introducing Mylan On Location™
This program is designed to help businesses, organizations and institutions offer immediate care in emergency situations.
Mylan On Location™ provides access to first-line medicine, and includes training, support services and instructions for proper storage and usage of the medication.
EpiPen® (epinephrine injection,USP) Auto-Injector is the first product featured in the Mylan On Location™ program.
Mylan On Location™ Services and Features:
- EpiPen 2-Pak® (epinephrine injection,USP) and EpiPen Jr 2-Pak® (epinephrine injection, USP) cartons
- In-store signage
- On-site consultation
- Automatic reminders
- Drug take-back/return
Join the Mylan On Location™ program today.
The need for anaphylaxis awareness
Up to 43 million people in the U.S. are at risk for anaphylaxis, a potentially severe or life-threatening allergic reaction, due to sensitivities to foods, insect venom and other allergens. That includes an estimated one in 13 children with food allergies, a common cause of anaphylaxis.
Avoidance of known allergic triggers is the most important step in managing life-threatening allergies, but sometimes these triggers are not obvious. When anaphylaxis occurs, every minute matters, and immediate access to epinephrine—the only first-line treatment for anaphylaxis—is critical.
As a global leader in providing treatment for life-threatening allergic reactions, Mylan is committed to increasing anaphylaxis awareness and access to emergency treatment.
A series of in-school tragedies over the past few years, have highlighted the need for immediate access for emergency treatment for anaphylaxis, particularly in U.S. schools. For this reason, we have worked hand in hand with key advocates, healthcare professionals, patients and third-party partners to successfully champion and expand legislation and policies—now enacted in 48 states—that allow or require schools to stock epinephrine auto-injectors.
Consistent with our dedication to breaking down barriers to access, in August 2012, we launched the EpiPen4Schools® program, which provides free EpiPen® Auto-Injectors and EpiPen Jr® Auto-Injectors to qualifying U.S. schools, along with additional training and educational resources. To date, more than 71,000 schools have participated nationwide.
Mylan’s public access initiative
Through collaboration with key advocates, healthcare professionals, patients and third-party partners, Mylan has started a new initiative to pass state legislation allowing access to epinephrine in establishments like restaurants, parks, camps, malls, college campuses and other public spaces. Before the introduction of our collaborative legislative efforts, no states had adopted a law. In the first year of our involvement, 30 states recognized the urgency with laws of their own.
Important Safety Information
Use EpiPen® (epinephrine injection, USP) 0.3 mg or EpiPen Jr® (epinephrine injection, USP) 0.15 mg Auto-Injectors right away when you have an allergic emergency (anaphylaxis). Get emergency medical help right away. You may need further medical attention. Only a healthcare professional should give additional doses of epinephrine if you need more than two injections for a single anaphylactic episode. EpiPen® or EpiPen Jr® should only be injected into the middle of your outer thigh (upper leg), through clothing if necessary. Do not inject into your veins, buttocks, fingers, toes, hands or feet. Hold the leg of young children firmly in place before and during injection to prevent injuries. In case of accidental injection, please seek immediate medical treatment.
Rarely, patients who have used EpiPen® or EpiPen Jr® may develop an infection at the injection site within a few days. Some of these infections can be serious. Call your healthcare professional right away if you have any of the following at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.
Tell your healthcare professional about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, high blood pressure or heart problems, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Be sure to also tell your healthcare professional all the medicines you take, especially medicines for asthma. If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have longer lasting side effects when you use EpiPen® or EpiPen Jr®.
Common side effects include fast, irregular or “pounding” heartbeat, sweating, nausea or vomiting, breathing problems, paleness, dizziness, weakness, shakiness, headache, feelings of over excitement, nervousness or anxiety. These side effects usually go away quickly if you lie down and rest. Tell your healthcare professional if you have any side effect that bothers you or that does not go away.
Please see the full Prescribing Information and Patient Information.
EpiPen® and EpiPen Jr® Auto-Injectors are for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for people who are at increased risk for these reactions. EpiPen® and EpiPen Jr® are intended for immediate administration as emergency supportive therapy only. Seek immediate emergency medical help right away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For additional information, please contact us at 800-395-3376.
EpiPen®, EpiPen Jr®, EpiPen 2-Pak®, EpiPen Jr 2-Pak® and EpiPen4Schools® are registered trademarks owned by the Mylan companies. Mylan On Location™ is a trademark of Mylan Inc.
© 2017 Mylan Specialty L.P. All rights reserved.